Related Experiment Video
Updated: Aug 7, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis
George C Bao1, Jian-Guang Wang, Ambrose Jong
1Division of Hematology/Oncology, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles, CA 90027, USA.
Abstract:
Cip/Kip family protein p21, a cyclin-dependent kinase (CDK) inhibitor, is directly transactivated by retinoic acid receptor alpha (RARalpha) upon retinoic acid (RA):RARalpha binding. Yet the role of p21 upregulation by RA in lymphoma cells remains unknown. Here, we show that, in human pre-B lymphoma Nalm6 cells, RA-induced proliferation inhibition results from massive cell death characterized by apoptosis. Upregulated p21 by RA accompanies caspase-3 activation and precedes the occurrence of apoptosis. p21 induction leads to increased p21 complex formation with cyclin E/CDK2, which occurs when cyclin E and CDK2 levels remain constant. CDK2 can alternatively promote apoptosis, but the mechanisms remain unknown. Data presented here suggest a novel RA-signaling, by which RA-induced p21 induction and complex formation with cyclin E/CDK2 diverts CDK2 function from normally driving proliferation to alternatively promoting apoptosis.
Insights
Retinoic acid (RA) induces lymphoma cell death by upregulating p21, a cyclin-dependent kinase (CDK) inhibitor. This p21 upregulation diverts CDK2 from proliferation to apoptosis, revealing a novel RA signaling pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Cip/Kip protein p21 acts as a cyclin-dependent kinase (CDK) inhibitor.
- Retinoic acid receptor alpha (RARalpha) directly transactivates p21 upon retinoic acid (RA) binding.
- The function of RA-induced p21 upregulation in lymphoma remains unclear.
Purpose of the Study:
- To investigate the role of p21 upregulation by RA in human pre-B lymphoma Nalm6 cells.
- To elucidate the mechanism by which RA inhibits lymphoma cell proliferation.
Main Methods:
- Treatment of Nalm6 cells with RA.
- Analysis of cell death, apoptosis markers (caspase-3 activation), and protein complex formation (p21 with cyclin E/CDK2).
- Assessment of cyclin E and CDK2 protein levels.
Main Results:
- RA induced proliferation inhibition in Nalm6 cells, characterized by massive apoptosis.
- RA-induced p21 upregulation preceded and accompanied caspase-3 activation.
- p21 formed complexes with cyclin E/CDK2, while cyclin E and CDK2 levels remained constant.
- CDK2's function was diverted from proliferation to apoptosis promotion.
Conclusions:
- RA induces apoptosis in lymphoma cells via p21 upregulation.
- p21/cyclin E/CDK2 complex formation is a key event in RA-induced apoptosis.
- A novel RA signaling pathway exists where p21 diverts CDK2 function to promote apoptosis, rather than proliferation.
More Related Videos
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation